Clinical trial Recruiting at 1 site Observational Ages 18 and up

Long-term evaluation of hip prostheses performance

Official title: Hip Prospective Study: Long-term Post-market Clinical Follow-up on the Use of SERF Hip Prostheses

Run by Societe dEtude, de Recherche et de Fabrication · NCT05956236 · Data updated 2026-11-12

This study is trying to see how well certain hip implants work and how safe they are for adults getting these devices over a 15-year period.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment5000 (estimated)
SponsorSociete dEtude, de Recherche et de Fabrication
Industry-sponsored
Locations1 site (Saint-Priest-en-Jarez)
StatusRecruiting
StartedApril 24, 2023
Main results expectedApril 2046
Study endsApril 2046
Registry record updatedApril 14, 2026
Trial IDNCT05956236 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 60-65 and older with severe hip pain or disability who have not sufficiently improved with other treatments.

Probably not a fit

Patients who are pregnant, breastfeeding, or unable to provide informed consent will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather long-term clinical data on hip prostheses as part of the Post-Market Clinical Follow-up (PMCF) process mandated by European regulations. It will involve a multicentric, prospective investigation over a 15-year period, focusing on the safety, performance, and benefits of these devices in real-life settings. Participants will be adults who are scheduled to receive specific hip implants from the manufacturer SERF, following an observation period of alternative treatments. The study is designed to ensure compliance with health authority requirements and improve patient outcomes.

Why it matters

Potential benefit: If successful, this study could provide valuable insights into the long-term effectiveness and safety of hip prostheses, leading to improved patient care.

How similar studies have gone: Other studies have shown the importance of long-term data collection for medical devices, indicating that this approach is both relevant and necessary.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female adults
* Planned to be implanted with investigational medical devices per the IFUs:

  * Implantation in skeletally mature adults (usually aged 60-65 and over), with an extremely painful and/or disabled joint and insufficiently improved by alternative treatment options after an observation period lasting from a few weeks to a few months
  * Implantation of investigational medical devices as integrated systems (all components from SERF, no component from another manufacturer)
  * For an intended purpose and indication listed in the IFUs
* Affiliated to French social security
* Who provided a dated and signed informed consent form

Exclusion Criteria:

* Patient protected by a French legal measure
* Patient not able to express his/her consent as deemed by the investigator
* Patient deprived of liberty or hospitalized without consent
* Pregnant or breastfeeding women
* Patient contraindicated to investigational medical devices implantation per the IFUs
* Patient contraindicated to radiographic follow-up
* Patient a priori not able to meet the follow-up visits as deemed by the investigator
* Patient not able to fulfil a self-assessment questionnaire as deemed by the investigator.

Where it's running

  • CHU St Etienne
    Saint-Priest-en-Jarez, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.